7.04 USD
↘ 0.27 (3.69%)AT CLOSE (11:59 AM EDT)
Precision BioSciences, Inc. Common Stock
DTILNASDAQ • USD
7.03
↘ 0.01 (0.14%)
POST MARKET (AS OF 07:08 PM EDT)
Post Market
AS OF 07:08 PM EDT
7.03
↘ 0.01 (0.14%)
Market: CLOSED
Open?$7.34
High?$7.34
Low?$7.00
Prev. Close?$7.31
Volume?209.9K
Avg. Volume?321.2K
VWAP?$7.15
Rel. Volume?0.65x
Bid / Ask
Bid?$6.95 × 200
Ask?$7.75 × 100
Spread?$0.80
Midpoint?$7.35
Valuation & Ratios
Market Cap?181.7M
Shares Out?25.8M
Float?24.3M
Float %?94.0%
P/E Ratio?N/A
P/B Ratio?1.97
EPS?-$1.77
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?13.32Strong
Quick Ratio?13.32Strong
Cash Ratio?12.43Strong
Debt/Equity?0.24Low
ValuationATTRACTIVELY VALUED
Score92/100
P/E?N/A▾
P/B?1.97CHEAP▾
P/S?5.30FAIR▾
P/FCF?N/A▾
EV/EBITDA?-1.8CHEAP▾
EV/Sales?2.72CHEAP▾
Returns & Efficiency
ROE?-49.6%WEAK▾
ROA?-29.6%WEAK▾
Cash Flow & Enterprise
FCF?$-65928000
Enterprise Value?$93.2M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
Employees
68
Market Cap
181.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2019-03-28
Address
302 EAST PETTIGREW STREET
DURHAM, NC 27701
Phone: 919-314-5512
DURHAM, NC 27701
Phone: 919-314-5512